Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
O-GlcNAcylation Orchestrates Wnt-Induced Bone Formation via
2026-06-10
This study uncovers how Wnt3a-mediated O-GlcNAcylation, through both rapid and sustained pathways, is indispensable for osteoblast-driven bone formation by rewiring aerobic glycolysis. The findings highlight a novel metabolic and post-translational axis, offering mechanistic insight into bone anabolism and potential new targets for osteoporosis research.
-
Tetracycline: Mechanistic Insights and Assay Design in Micro
2026-06-10
Discover the multifaceted role of tetracycline, a broad-spectrum polyketide antibiotic, in advancing microbiological assay design and ribosomal research. This article uniquely bridges molecular mechanism, protocol optimization, and recent telomerase regulation breakthroughs to inform experimental strategies.
-
3-Methyladenine in Autophagy Research: Protocols & Insights
2026-06-09
3-Methyladenine (3-MA) stands apart as a precision autophagy inhibitor, enabling nuanced dissection of phosphoinositide 3-kinase signaling in cancer and virology. This guide translates experimental best practices, new mechanistic findings, and troubleshooting tips into actionable workflows for advanced research.
-
Dihydroartemisinin: Advanced Workflows for Malaria and mTOR
2026-06-09
Dihydroartemisinin, a potent Artemisia plant extract, delivers high-impact utility in malaria modeling and mTOR pathway inhibition. This guide demystifies experimental workflows, protocol enhancements, and troubleshooting tactics for extracting maximum value from APExBIO’s high-purity dihydroartemisinin in translational research.
-
BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid
2026-06-08
BODIPY 581/591 C11 stands out as a robust, ratiometric fluorescent probe for precise, quantitative lipid peroxidation detection in live cells and membranes. Its unique red-to-green spectral shift, high photostability, and selectivity for oxygen radicals streamline workflows and empower advanced oxidative stress research across cardiovascular, neurodegenerative, and ferroptosis studies.
-
Bacitracin (B1670): Technical Guidance for Antibacterial Res
2026-06-08
Bacitracin is a peptide antibiotic designed for laboratory workflows investigating bacterial cell wall and peptidoglycan synthesis disruption. It is suitable for controlled antibacterial research targeting both gram-positive and gram-negative bacteria, but should not be used for diagnostic or medical purposes.
-
Q-VD-OPh: Pan-Caspase Inhibitor Empowering Apoptosis Researc
2026-06-07
Q-VD-OPh stands out as a potent, cell-permeable pan-caspase inhibitor driving precision in apoptosis research and neurodegeneration studies. This article details advanced workflows, actionable troubleshooting, and the latest mechanistic insights, linking foundational protocol optimization with cutting-edge virology and disease models.
-
Trichostatin A in Epigenetic Regulation: Protocols and Insig
2026-06-06
Trichostatin A (TSA) is a gold-standard HDAC inhibitor, enabling precise epigenetic modulation for cancer and organoid research. This article offers protocol-driven guidance, real-world troubleshooting, and actionable insights—bridging foundational studies with next-generation workflows.
-
Acridine Orange hydrochloride: Technical Use in Nucleic Acid
2026-06-05
Acridine Orange hydrochloride provides reliable, differential staining of DNA and RNA for cytochemical applications such as cell cycle analysis, apoptosis detection, and flow cytofluorometric studies. It is not intended for non-cytochemical protocols or for situations requiring long-term solution storage, ensuring maximum performance in workflows where nucleic acid discrimination is critical.
-
Dual Luciferase Reporter Gene System: Precision in Gene Expr
2026-06-05
Unlock high-sensitivity gene expression regulation studies with the Dual Luciferase Reporter Gene System. Learn how APExBIO's workflow innovations and troubleshooting strategies empower transcriptional regulation research, as demonstrated in recent oncology breakthroughs.
-
Optimizing Mitochondrial Assays with FCCP (carbonyl cyanide
2026-06-04
This article addresses core workflow challenges in mitochondrial biology research using FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), SKU B5004. Drawing on validated protocols and quantitative evidence, it guides researchers through experimental design, data interpretation, and reagent selection for robust, reproducible results with FCCP.
-
P/Q-Type Calcium Channel Blockade Fails to Prevent Veratridi
2026-06-04
The referenced study rigorously investigated whether o-agatoxin IVA, a selective P/Q-type calcium channel antagonist, can prevent excitotoxic neuronal injury in cortical cultures induced by veratridine and other depolarizing agents. Despite its ability to inhibit glutamate release, o-agatoxin IVA did not confer neuroprotection, highlighting a dissociation between synaptic glutamate release inhibition and overall excitotoxicity under these experimental conditions.
-
RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy & C
2026-06-03
RapaLink-1, a third-generation mTOR inhibitor from APExBIO, empowers researchers to induce reversible embryonic dormancy and achieve robust cancer cell growth inhibition, even in the face of resistant mutations. By leveraging its bivalent mechanism and validated protocols, scientists can streamline workflows and generate reproducible results across oncology and developmental biology.
-
Pharmacokinetic Profile of Temafloxacin: Implications for Re
2026-06-03
This review by Dudley (1991) provides a comprehensive analysis of temafloxacin’s pharmacokinetics, highlighting its high oral bioavailability, extensive tissue distribution, and flexible dosing for antibacterial research. These characteristics underpin its utility as a fluoroquinolone broad-spectrum antibacterial agent in both clinical and laboratory research contexts.
-
CDC42-Dependent Polarity Directs Intestinal Stem Cell Fate v
2026-06-02
This study elucidates how CDC42-regulated apical-basal polarity orchestrates the balance between intestinal stem cells and transit amplifying cells through a Hippo-YAP-EGF-mTOR signaling cascade, independent of canonical Wnt pathways. The findings clarify the molecular basis of epithelial homeostasis and provide actionable insight for researchers investigating gastrointestinal regeneration and stem cell modulation.